The National Cancer Institute approved a program June 21 to create a blockchain-based system that allows users to share clinical data.
Starting at the Rensselaer Polytechnic Institute, the program will leverage IBM's Hyperledger blockchain. Users of the blockchain, including providers, patients and researchers, will be able to share data more efficiently.
Traditionally, clinical data has been stored across multiple parties, which can cause friction.
"Failure in timely access to health information could impede effective treatment decision-making, which will adversely affect patient health, and also incur unnecessary costs such as duplicated tests," the institute said.
To read more, click here.